Arrow acquisition boosts Watson's 2009 performance
This article was originally published in Scrip
Executive Summary
Watson Pharmaceuticals' acquisition of Arrow in early December helped to boost its full-year 2009 net revenues to $2.8 billion, 10% higher than in 2008.